Skip to main content

Table 4 Patient Characteristics in the Propensity Model

From: Statin use is associated with a lower risk of recurrence after curative resection in BCLC stage 0-A hepatocellular carcinoma

Variable

Statin (n = 46)

Non-statin (n = 174)

P-value

SMD

Age, years; mean (SD)

62.02 (8.14)

62.38 (9.35)

0.957

0.041

Sex

  

0.975

0.005

Male

40 (87.0%)

151 (86.8%)

  

Female

6 (13.0%)

23 (13.2%)

  

Diabetes

27 (58.7%)

94 (54.0%)

0.572

0.094

HBV

22 (47.8%)

78 (44.8%)

0.717

0.059

HCV

14 (30.4%)

56 (32.2%)

0.821

0.037

Liver cirrhosis

12 (26.1%)

51 (29.3%)

0.668

0.072

Child-Pugh grade

  

0.826

0.037

A

42 (91.3%)

157 (90.2%)

  

B

4 (8.7%)

17 (9.8%)

  

Tumor size (> 2 cm)

42 (91.3%)

162 (93.1%)

0.677

0.067

Tumor number

  

0.449

0.114

Single

44 (95.7%)

170 (97.7%)

  

Multiple

2 (4.3%)

4 (2.3%)

  

Vascular invasion

22 (47.8%)

77 (44.3%)

 

0.071

  1. SMD Standardized mean difference, HBV Hepatitis B virus, HCV Hepatitis C virus